LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Possible neglected transient (T) polyagglutination in critically ill patients with coronavirus disease-2019 (Covid-19).

Gasim Dobie, - / Hassan A Hamali, - / Abdullah A Mobarki, - / Muhammad Saboor, - / Mohammad S Akhter, - / Khaled Essawi Abdulrahim R Hakami, - / Mohammed H Nahari, - / Mohamed A Kolaiby, - / Yahya H Matari, - / Essa Atafi, - / Ghalib Ghubiri, - / Abdulrahman A Alhamzi, - / Abdulrhman Alhamzi, - / Amr J Halawani, - / Abdullah Hamadi, - / Denise E Jackson, -

Pakistan journal of pharmaceutical sciences

2023  Volume 36, Issue 4, Page(s) 1211–1215

Abstract: T-activation polyagglutination can be caused by bacteria or viruses and has been associated with haemolytic anaemia. Coronavirus disease-19 (COVID-19) is also associated with haemolytic anaemia. The presented study aims to determine T activation ... ...

Abstract T-activation polyagglutination can be caused by bacteria or viruses and has been associated with haemolytic anaemia. Coronavirus disease-19 (COVID-19) is also associated with haemolytic anaemia. The presented study aims to determine T activation polyagglutination in critically ill COVID-19 patients. Anti-T Arachis hypogaea lectin was incubated with the red blood cells of the COVID-19 patient and checked for agglutination. Thirty-four percent (34.3%) of COVID-19 patients in the intensive care unit (ICU) had potentially activated T cells and polyagglutinable red blood cells, as demonstrated by their cryptantigen exposure that caused agglutination. The study revealed a high prevalence of anti-T among ICU-admitted COVID-19 patients, suggesting that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may cause transient T activation, polyagglutination in critically ill COVID-19 patients in vitro and possibly haemolysis in vivo.
MeSH term(s) Humans ; COVID-19 ; SARS-CoV-2 ; Critical Illness ; Antibodies ; Cell Death
Chemical Substances Antibodies
Language English
Publishing date 2023-08-21
Publishing country Pakistan
Document type Journal Article
ZDB-ID 885131-1
ISSN 1011-601X
ISSN 1011-601X
Shelf mark
Zs.A 6588: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top